Proteoglycans in Lung Disease

Portada
CRC Press, 16 oct 2002 - 480 páginas

Discusses new treatment strategies for malignant mesothelioma, pulmonary edema, fibrosis, asthma, emphysema, and bronchiectasis.

Proteoglycans in Lung Disease considers

  • glycosaminoglycans as novel therapeutic agents or targets in lung disease
  • the role of proteoglycans in determining mechanical behavior of lung tissue
  •  

    Páginas seleccionadas

    Índice

    Chapter 1 Proteoglycans of the Lung
    1
    Chapter 2 Hyaluronan in Lung Function
    23
    Chapter 3 Morphological Tools for Studying Lung Proteoglycans
    37
    Chapter 4 Proteoglycans Lung Physiology and Mechanical Strain
    55
    Chapter 5 Hyaluronan and Its Receptors in Lung Health and Disease
    73
    Chapter 6 Hyaluronan and Hyaladherin Signaling in the Lung
    107
    Chapter 7 Hyaluronan in Malignant Mesothelioma
    135
    Chapter 8 Matrix Proteoglycans in Development of Pulmonary Edema
    143
    Chapter 12 Role of Proteoglycans in the Development and Pathogenesis of Emphysema
    241
    Chapter 13 Proteoglycans in Normal and Pathological Bronchial Mucus
    269
    Chapter 14 Vascular Proteoglycans
    291
    Chapter 15 Degradation of Lung Matrix Proteoglycans in Bronchiectasis
    323
    Chapter 16 Effect of Hypoxia on Glycosaminoglycan Synthesis by Lung Cells
    335
    Chapter 17 Integrins Proteoglycans and Lung Disease
    351
    Chapter 18 Heparin as a Potential Therapeutic Agent to Reverse Vascular Remodeling
    377
    AUTHOR INDEX
    399

    Chapter 9 The Role of Small Proteoglycans in the Formation of Fibrosis
    169
    Chapter 10 Versican in the Cell Biology of Pulmonary Fibrosis
    191
    Chapter 11 Decorin in Asthma
    213

    Otras ediciones - Ver todo

    Términos y frases comunes

    Sobre el autor (2002)

    Hari G. Garg

    Información bibliográfica